WallStreetZenWallStreetZen

NASDAQ: NVCR
Novocure Ltd Stock Ownership - Who owns Novocure?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Novocure Ltd insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Frank X. LeonardEVP Pres. Novocure Oncology2024-03-04840$16.01
$13.45kSell
Wilhelmus Cm GroenhuysenChief Operating Officer2024-03-041,217$16.01
$19.48kSell
Wilhelmus Cm GroenhuysenChief Operating Officer2024-03-012,107$16.03
$33.77kSell
Frank X. LeonardEVP Pres. Novocure Oncology2024-03-011,679$16.03
$26.91kSell
Wilhelmus Cm GroenhuysenChief Operating Officer2024-02-282,303$16.14
$37.18kSell
Frank X. LeonardEVP Pres. Novocure Oncology2024-02-282,078$16.14
$33.55kSell
Michal Nath PuriChief Human Resources Officer2024-02-2771,574$16.30
$1.17MBuy
URI WeinbergChief Innovation Officer2024-02-2781,799$16.30
$1.33MBuy
Moshe GiladiChief Science Officer2024-02-2751,124$16.30
$833.32kBuy
Frank X. LeonardEVP Pres. Novocure Oncology2024-02-27102,249$16.30
$1.67MBuy

1 of 4

NVCR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NVCR insiders and whales buy or sell their stock.

NVCR Shareholders

What type of owners hold Novocure Ltd stock?
Institutional
Insider
Retail
NameHoldSharesValueType
William F. Doyle23.75%25,430,468$321.31MInsider
Fmr LLC14.91%15,962,767$201.69MInstitution
Gert L. Perlhagen13.09%14,018,365$177.12MInsider
Hansjoerg Wyss9.13%9,780,397$123.58MInsider
Vanguard Group Inc9.11%9,759,098$123.31MInstitution
Capital International Investors8.27%8,861,871$111.97MInstitution
Blackrock Inc8.21%8,792,035$111.09MInstitution
Volati Ltd6.74%7,216,789$91.18MInsider
Baillie Gifford Co4.52%4,840,141$61.16MInstitution
State Street Corp3.61%3,863,549$48.82MInstitution

1 of 3

NVCR vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NVCR58.51%41.49%Net BuyingNet Buying
AHCO45.39%54.61%Net SellingNet Selling
ESTA73.01%23.05%Net BuyingNet Buying
INMD62.26%0.00%
UFPT82.80%17.20%Net SellingNet Selling
View Top Medical Device Stocks

Novocure Stock Ownership FAQ

Who owns Novocure?

Novocure (NASDAQ: NVCR) is owned by 84.50% institutional shareholders, 59.91% Novocure insiders, and 0.00% retail investors. William F. Doyle is the largest individual Novocure shareholder, owning 25.43M shares representing 23.75% of the company. William F. Doyle's Novocure shares are currently valued at $321.31M.

If you're new to stock investing, here's how to buy Novocure stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.